SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-17-005989
Filing Date
2017-10-30
Accepted
2017-10-30 16:11:30
Documents
8
Period of Report
2017-10-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K s107884_8k.htm 8-K 29842
2 EXHIBIT 1.1 s107884_ex1-1.htm EX-1.1 278749
3 EXHIBIT 5.1 s107884_ex5-1.htm EX-5.1 5160
4 EXHIBIT 99.1 s107884_ex99-1.htm EX-99.1 12149
5 EXHIBIT 99.2 s107884_ex99-2.htm EX-99.2 11046
6 GRAPHIC img001_v1.jpg GRAPHIC 17924
7 GRAPHIC image_001.jpg GRAPHIC 6459
8 GRAPHIC image_002.jpg GRAPHIC 5100
  Complete submission text file 0001615774-17-005989.txt   379067
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA GENETICS INC (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35610 | Film No.: 171162454
SIC: 2834 Pharmaceutical Preparations